Muscular Dystrophy Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
For people with myotonic dystrophy (DM):
- You are between 18 and 65 years old
- You have been diagnosed with myotonic dystrophy type 1 or type 2, either through genetic testing or by a doctor based on your symptoms (if diagnosed by symptoms only, a close blood relative must have had genetic confirmation and agree to share that information)
- You have noticeable symptoms such as muscle weakness or muscle stiffness/spasms (myotonia)
- You are able to walk on your own without using a walker
- You are able to understand and agree to take part in the study yourself
For healthy comparison participants (control subjects):
- You are between 18 and 65 years old
- You are in good general health with no significant medical or neurological conditions
- You are able to understand and agree to take part in the study yourself
Who may not be able to join:
- You have a cardiac pacemaker, a defibrillator, metal implants in your body, or anything else that would make it unsafe for you to have an MRI scan
- You have used certain muscle-affecting medications or supplements (anabolic or catabolic agents) within the past year
- You have a history of lower back or leg surgery, lower back nerve problems, or nerve damage in your limbs
- Your BMI (a measure of body weight relative to height) is above 35, as this can make positioning in the MRI scanner difficult
- You are pregnant
- For the muscle biopsy part of the study: you have a history of bleeding disorders or are taking blood-thinning medication (note: if you take anti-inflammatory painkillers like ibuprofen, you may be asked to stop taking them 7 days before the biopsy — confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Araya Puwanant, MD, Wake Forest University Health Sciences
Phone: 336-716-4163
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Contractile muscle volume (CMV, cm3); Muscle fat fraction (MFF, %)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.